Monthly Archives: August 2011

Pharma Failing to eMarket Effectively

By Guest Blogger | Published: August 31, 2011
Pharma must overcome its social media phobia and embrace new technology if it wants to keep the audience that matters most, writes Lauren Procter of L2 Think Tank. Consumers and healthcare practitioners have come to rely on digital platforms for medical advice, but as Google trumps nurses, pharmacists, and friends and family as the second most [...]
Posted in Guest Blog, Strategy, Technology, social media | Tagged , , , , | 4 Comments

Europe Wrestles with Outdated Clinical Research Rules

By Guest Blogger | Published: August 31, 2011
By Reflector, Brussels correspondent. Man can live as a free being only when he is free to develop his innate abilities, maintained Baruch Spinoza, that quintessential European, back in the 17th century. He might have been talking about the aspirations in the European pharmaceutical sector, which is currently struggling to articulate a clear plan for escaping [...]
Posted in Europe, Global, Guest Blog, R&D, Regulatory | Tagged , , , | 1 Comment

Without An Rx, Some Pharmas Are Skittish

By Ben Comer | Published: August 24, 2011
Lower margins and strong-arm direct-to-consumer campaigns are two of the primary barriers to selling nutraceuticals, according to a business school ‘war game’ conducted with the participation of Abbott, Danone (Dannon in the US), GSK and Nestlé. But the global nutraceuticals market – worth $80 billion in 2010, according to Frost & Sullivan – is expected [...]
Posted in Advertising, Global, IP, Marketing, Regulatory, Strategy, patient education | Tagged , , , | 4 Comments

Pharma's Influence on the Super Committee: Is Cash Really King?

By Ben Comer | Published: August 16, 2011
Three of the twelve appointees to the Joint Select Committee on Deficit Reduction (aka Super Committee) received over $300,000 in campaign contributions from pharmaceutical companies, according to Center for Responsive Politics data, and a MapLight analysis.
Posted in Strategy, healthcare, leadership | Tagged , , , , , , | 1 Comment

Facebook: Should I Stay or Should I Go?

By Guest Blogger | Published: August 12, 2011
By Thomas L. Harrison We like to be heard if we’re willing to listen. And yet, until now, pharmaceutical companies with a presence on Facebook have understandably been reluctant to “listen” by allowing consumers to post comments on their Facebook pages.
Posted in Strategy | 2 Comments